UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 59

Sortiert nach

Combination Chemotherapy With Gemcitabine Plus Oxaliplatin in Patients With Intensively Pretreated or Refractory Germ Cell Cancer: A Study of the German Testicular Cancer Study Group

Journal of clinical oncology, 2004-01, Vol.22 (1), p.108-114

2004

Volltextzugriff (PDF)

Efficacy of Contralateral Prophylactic Mastectomy in Women With a Personal and Family History of Breast Cancer

Journal of clinical oncology, 2001-10, Vol.19 (19), p.3938-3943

2001

Volltextzugriff (PDF)

Long-Term Results of First-Line Sequential High-Dose Etoposide, Ifosfamide, and Cisplatin Chemotherapy Plus Autologous Stem Cell Support for Patients With Advanced Metastatic Germ Cell Cancer: An Extended Phase I/II Study of the German Testicular Cancer Study Group

Journal of clinical oncology, 2003-11, Vol.21 (22), p.4083-4091

2003

Volltextzugriff (PDF)

Association Between Mammographic Density and Age-Related Lobular Involution of the Breast

Journal of clinical oncology, 2010-05, Vol.28 (13), p.2207-2212

2010

Volltextzugriff (PDF)

Extragonadal Germ Cell Tumors of the Mediastinum and Retroperitoneum: Results From an International Analysis

Journal of clinical oncology, 2002-04, Vol.20 (7), p.1864-1873

2002

Volltextzugriff (PDF)

Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy

Journal of clinical oncology, 2010-11, Vol.28 (33), p.4906-4911

2010

Volltextzugriff (PDF)

Role of Genetic and Nongenetic Factors for Fluorouracil Treatment-Related Severe Toxicity: A Prospective Clinical Trial by the German 5-FU Toxicity Study Group

Journal of clinical oncology, 2008-05, Vol.26 (13), p.2131-2138

2008

Volltextzugriff (PDF)

Second-Line Chemotherapy in Patients With Relapsed Extragonadal Nonseminomatous Germ Cell Tumors: Results of an International Multicenter Analysis

Journal of clinical oncology, 2001-03, Vol.19 (6), p.1641-1648

2001

Volltextzugriff (PDF)

Risk Factors for Relapse in Clinical Stage I Nonseminomatous Testicular Germ Cell Tumors: Results of the German Testicular Cancer Study Group Trial

Journal of clinical oncology, 2003-04, Vol.21 (8), p.1505-1512

2003

Volltextzugriff (PDF)

T-Cell Immunity to the Folate Receptor Alpha Is Prevalent in Women With Breast or Ovarian Cancer

Journal of clinical oncology, 2006-09, Vol.24 (26), p.4254-4261

2006

Volltextzugriff (PDF)

Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry

Journal of clinical oncology, 1998-03, Vol.16 (3), p.953-965

1998

Volltextzugriff (PDF)

Purging of bone marrow in autologous bone marrow transplantation for non-Hodgkin's lymphoma: a case-matched comparison with unpurged cases by the European Blood and Marrow Transplant Lymphoma Registry

Journal of clinical oncology, 1996-09, Vol.14 (9), p.2454-2464

1996

Volltextzugriff (PDF)

Impact of reconstruction on satisfaction with contralateral prophylactic mastectomy

Journal of clinical oncology, 2011-09, Vol.29 (27_suppl), p.240-240

2011

Volltextzugriff (PDF)

Expression and function of the sphingolipid receptors S1P1–5 in Ewing and adult type soft tissue sarcoma cells: Examples of G protein-coupled receptors as potential new treatment targets

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.10581-10581

2008

Volltextzugriff (PDF)

Performance of the Gail model in individual women with benign breast disease

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.1525-1525

2011

Volltextzugriff (PDF)

A phase I pharmacokinetic and safety analysis of epothilone folate (BMS-753493): A first-in-human clinical experience of a folate receptor-targeted chemotherapeutic agent dosed once daily on days 1, 2, 3, and 4 of a 21-day cycle

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e13005-e13005

2010

Volltextzugriff (PDF)

Influence of expression of estrogen (ERS-1) and progesterone (PGR) receptors on metastatic spread and outcome in non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.7585-7585

2011

Volltextzugriff (PDF)

Molecular subtypes, body mass index (BMI), and their time-varying prognostic impact in node-positive breast cancer (BC): Pooled analysis from the WSG AM-01 and -02 trials

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.1021-1021

2011

Volltextzugriff (PDF)

Comparison of predictive and prognostic impact of molecular subtypes and central grade regarding taxane-based therapy in intermediate-risk breast cancer: Results from the EC-Doc trial

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.10625-10625

2011

Volltextzugriff (PDF)

First-line treatment patterns for recurrent and/or metastatic head and neck cancer (R/M HNC) in Europe

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e16016-e16016

2010

Volltextzugriff (PDF)

Prospective evaluation of predictive and prognostic molecular markers in colorectal carcinomas

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e14114-e14114

2010

Volltextzugriff (PDF)

Clinicopathological characteristics of subsequent breast cancers in patients with benign breast disease

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.1061-1061

2009

Volltextzugriff (PDF)

Pharmacokinetics, safety and efficacy of pegfilgrastim in dose-dense, sequential adjuvant chemotherapy for patients with breast cancer (BC)

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.13546-13546

2008

Volltextzugriff (PDF)

Matrix metalloproteinase-9 (MMP-9) and vascular endothelial growth factor (VEGF) mRNA expression in patients with metastatic gastric cancer receiving first-line chemotherapy

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.4547-4547

2009

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(59)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(19)
Oncology
(18)
Life Sciences & Biomedicine
(17)
Science & Technology
(17)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Male
(14)
Adult
(11)
Middle Aged
(11)
Female
(10)
Adolescent
(9)
Prognosis
(9)
Tumors
(7)
Aged
(6)
Antineoplastic Agents
(6)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(6)
Child
(6)
Pharmacology. Drug Treatments
(6)
Retrospective Studies
(6)
Risk Factors
(6)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

J. Clin. Oncol
(1)

Menü

Weitere Dienste

Einstellungen

Combination Chemotherapy With Gemcitabine Plus Oxaliplatin in Patients With Intensively Pretreated or Refractory Germ Cell Cancer: A Study of the German Testicular Cancer Study Group

Efficacy of Contralateral Prophylactic Mastectomy in Women With a Personal and Family History of Breast Cancer

Long-Term Results of First-Line Sequential High-Dose Etoposide, Ifosfamide, and Cisplatin Chemotherapy Plus Autologous Stem Cell Support for Patients With Advanced Metastatic Germ Cell Cancer: An Extended Phase I/II Study of the German Testicular Cancer Study Group

Association Between Mammographic Density and Age-Related Lobular Involution of the Breast

Extragonadal Germ Cell Tumors of the Mediastinum and Retroperitoneum: Results From an International Analysis

Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy

Viable Malignant Cells After Primary Chemotherapy for Disseminated Nonseminomatous Germ Cell Tumors: Prognostic Factors and Role of Postsurgery Chemotherapy—Results From an International Study Group

Role of Genetic and Nongenetic Factors for Fluorouracil Treatment-Related Severe Toxicity: A Prospective Clinical Trial by the German 5-FU Toxicity Study Group

Second-Line Chemotherapy in Patients With Relapsed Extragonadal Nonseminomatous Germ Cell Tumors: Results of an International Multicenter Analysis

Risk Factors for Relapse in Clinical Stage I Nonseminomatous Testicular Germ Cell Tumors: Results of the German Testicular Cancer Study Group Trial

T-Cell Immunity to the Folate Receptor Alpha Is Prevalent in Women With Breast or Ovarian Cancer

Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry

Purging of bone marrow in autologous bone marrow transplantation for non-Hodgkin's lymphoma: a case-matched comparison with unpurged cases by the European Blood and Marrow Transplant Lymphoma Registry

Impact of reconstruction on satisfaction with contralateral prophylactic mastectomy

Expression and function of the sphingolipid receptors S1P1–5 in Ewing and adult type soft tissue sarcoma cells: Examples of G protein-coupled receptors as potential new treatment targets

Performance of the Gail model in individual women with benign breast disease

A phase I pharmacokinetic and safety analysis of epothilone folate (BMS-753493): A first-in-human clinical experience of a folate receptor-targeted chemotherapeutic agent dosed once daily on days 1, 2, 3, and 4 of a 21-day cycle

Influence of expression of estrogen (ERS-1) and progesterone (PGR) receptors on metastatic spread and outcome in non-small cell lung cancer (NSCLC)

Molecular subtypes, body mass index (BMI), and their time-varying prognostic impact in node-positive breast cancer (BC): Pooled analysis from the WSG AM-01 and -02 trials

Comparison of predictive and prognostic impact of molecular subtypes and central grade regarding taxane-based therapy in intermediate-risk breast cancer: Results from the EC-Doc trial

First-line treatment patterns for recurrent and/or metastatic head and neck cancer (R/M HNC) in Europe

Prospective evaluation of predictive and prognostic molecular markers in colorectal carcinomas

Clinicopathological characteristics of subsequent breast cancers in patients with benign breast disease

Pharmacokinetics, safety and efficacy of pegfilgrastim in dose-dense, sequential adjuvant chemotherapy for patients with breast cancer (BC)

Matrix metalloproteinase-9 (MMP-9) and vascular endothelial growth factor (VEGF) mRNA expression in patients with metastatic gastric cancer receiving first-line chemotherapy

Aktive Filter

Suchergebnisse filtern